Bristol-Myers Squibb Company

Translational Medicine Business Strategy and Operations Lead

Princeton, NJ, US
Oct 08, 2018
Required Education
Bachelors Degree
Position Type
Full time
Translational medicine is central to our work at BMS. As the industry's leading translational medicine organization, our teams are transforming patient outcomes through next-generation science and technology. Our research focuses on addressing unmet medical needs in oncology, cardiovascular disease, immunoscience, and fibrosis. We are entering into a new era of translational medicine, which reinforces the importance of finding innovative ways to accelerate decision making and leverage learnings across teams to deliver the right medicines to the right patients, at the right time. Powered by world-class talent, our capabilities are integrated throughout the enterprise and are united under the mission to help patients prevail over serious diseases.

The Translational Medicine (TM) Business Strategy and Operations Lead is the chief-of-staff to the TM Leadership Team (LT) comprising SVPs, VPs, & Function Heads. The role partners closely with the TM LT to design and execute the division's strategy with industry-leading operational efficiency and organizational engagement. The role will provide business management advisory, business operations excellence, continuous improvement, performance measurement, and stakeholder management to ensure tangible value delivery to our patients, our people, and our business. The role is part of the R&D Strategy and Planning (RDSP) division, which is accountable for R&D business strategy, business and research operations, operational transformations, drug development project & portfolio management, and R&D learning. The role reports to the Head of Business Strategy & Operations for the Discovery and Translational Medicine divisions of BMS R&D.

The role will manage a team of 2 - 3 RDSP business operations specialists to deliver on the expectation of world-class business management support to the TM organization. The role will also partner closely with global Translational Medicine, Discovery, R&D, and RDSP leaders, stakeholders, and enterprise business partners to ensure organizational alignment and business performance excellence. Core enterprise business partners include Finance, Human Resources, Procurement, Information Technology, Business Insights & Analytics, Business Development, Facilities, Legal, Government Affairs, Corporate Affairs, and others. Accordingly, it is critical that the candidate effectively partner with and engage a matrixed team of internal and external partners.

Core responsibilities of the TM Business Strategy and Operations Lead are:
  • Facilitating the development and broad communication of the TM divisional strategy, and how it delivers tangible value to our patients, our people, and our company
  • Translating divisional strategy into objectives and programs / initiatives with clearly defined plans that deliver short- and mid-term value, and managing their delivery to successful completion
  • Proactively incorporating enterprise and industry perspectives into TM strategy and objectives
  • Ensuring industry-leading TM performance; example measures include:
    • Achievement of TM contributions to pipeline goals and enterprise value
    • Achievement of TM strategy, objectives, and critical programs & initiatives
    • Impact of scientific and capability investments, contributions to R&D innovation and thought leadership
    • Operational performance (speed, cost, quality, resource efficiency, etc.), Financial performance (OpEx, CapEx, other), Headcount management and resource allocation, Business continuity
    • Culture and employee engagement, Workspace effectiveness
    • Internal and external relationships and connectivity
  • Proactively identifying and mitigating risks to divisional performance and business value delivery
  • Ensuring functional alignment with TM strategy and objectives, and ensuring that the organization is aware of and focused on the highest priority work
  • Assisting functional leaders with the design and implementation of their business strategies
  • Leading the development and management of a continuous business improvement strategy for TM, including implementation of and change management for major business initiatives that deliver tangible scientific and business value; selected examples include:
    • Identifying opportunities to accelerate decision making and enhance business impact of investments
    • Facilitating the assessment and uptake of novel scientific capabilities and technology platforms
    • Facilitating the improvement in outcomes & efficiency of core R&D activities and business processes
    • Fostering cross-functional synergies across the enterprise and with strategic external partners
    • Optimizing the utility of project, information, and business management capabilities
  • Serving as the chief-of-staff to the TM Leadership Team
    • Plan and facilitate LT and divisional meetings, committees, and workshops
    • Plan and facilitate portfolio and business performance reviews
    • Manage internal communication strategy, ensuring broad dissemination of strategy, decisions, events, etc.
    • Plan and prepare Townhalls, communications, and connectivity events
    • Prepare strategy and performance updates for R&D LT, BMS LT, and the Board
    • Advise TM LT on divisional performance and potential risks, and provide recommended mitigations
    • Ensure TM LT are apprised of relevant enterprise and divisional initiatives and available tools (project & business management, onboarding, meeting management, etc.)
  • Ensuring broad visibility to drivers of TM workload and ensuring adequate resourcing or tradeoffs / prioritization occurs to ensure sustainable delivery and resource utilization
  • Ensuring adherence to divisional and functional operating budgets
  • Managing global headcount processes for various staffing models
  • Developing and managing the TM staff engagement and internal communication plan and leading selected engagement initiatives
  • Monitoring the external landscape to stay abreast of industry and business management macro trends to inform and educate stakeholders, and incorporate into TM business management

  • Undergraduate (BA/BS) degree required; advanced scientific degree or MBA preferred
  • 10 years of professional experience in the life sciences or biopharmaceutical industry
  • Scientific experience in translational medicine preferred
  • Business strategy and operations experience required; management consulting experience preferred
  • Demonstrated strength in assessing business-critical needs, developing business strategy, operating models, and plans, managing program execution, and delivering measureable business value
  • Strong experience with business process design and performance measurement
  • Strong business acumen and comfort in agile delivery and learning environment
  • Capable of bringing structure to vaguely defined problems while using creative yet pragmatic problem-solving approaches and execution management
  • Highly effective written and verbal communication and interpersonal skills
  • Strong presentation, facilitation, and executive-level messaging skills
  • Ability to build relationships and influence, and drive organizational engagement
  • Strong matrixed team leadership, mentoring, and people development & inclusion skills
  • Strong ability to ensure connectivity across multiple functions within a site and with the enterprise

About BMS R&D

Bristol-Myers Squibb R&D is a science-driven, passionate organization determined to discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need. Patients' needs and scientific discovery are our driving force.

We have a history of scientific excellence. We dramatically changed outcomes in HIV; we helped discover a cure for HCV; and we developed a novel medicine with proven benefit for atrial fibrillation. We also pioneered targeting the immune system in cancer research, breaking new ground in the science of immuno-oncology.

Today, we are transforming the way certain cancers are treated and focusing our research efforts on areas of high unmet need in cardiovascular disease, immunoscience and fibrosis. Our goal is to leave an enduring positive impact on society by making a meaningful difference in the lives of even more patients.

Our people are our greatest asset. Our R&D organization is made up of industry-leading researchers and drug developers who have a passion for science, a curiosity for discovery and a commitment to translating these advances into medicines that make a difference for patients. Our teams are part of a unique global ecosystem that is set up to be agile, interactive and conducive to translating a nascent idea into a powerful treatment.

We follow the science. Our pipeline of promising molecules and medicines is deliberately built through a multi-disciplinary, collaborative approach. We are deepening our understanding of disease biology and uncovering biomarker insights to help predict how patients will respond to treatment with the ultimate goal of making precision medicine a reality for more patients.

We believe partnership and collaboration are essential. Academic research centers, laboratories, clinicians, clinical trials organizations, government, advocates and industry - all of these organizations contribute to a vibrant healthcare ecosystem that is critical to continued scientific advancement. From the global research networks we've created to our creative approach to business development, we complement internal innovation with external innovation - identifying new scientific hypotheses to better understand how to translate research findings into improved patient outcomes.

We believe digital health and data connectivity is transforming our industry. Over the past few years, there has been an explosion of available electronic medical records, genomics and claims data. This, combined with our own data, biomedical and health informatics partnerships, and new analytical tools, is changing how we interact with payers, suppliers and patients. By leveraging the collective power of data & analytics, we are accelerating the pipeline, enhancing the speed of clinical trials, demonstrating the value of our medicines and helping to inform clinical decisions.

We are constantly anticipating what's coming next, navigating and discovering new technologies, enabling our understanding of new ways to use them and applying them to advance drug discovery, development and delivery to patients as quickly as possible.

Our mission is clear: to discover, develop and deliver innovative medicines to patients with serious diseases.